Michael S. Weiss
Overview
Michael S. Weiss received an average of $9.3M in compensation at TG Therapeutics from 2011 to 2018, an average of $5.3M at Fortress Biotech from 2014 to 2016,, and an average of $4.3M at Keryx Biopharmaceuticals from 2006 to 2009.
YearCompanyPositionCompensation
2018
TG TherapeuticsChief Executive Officer and President$14M2017
TG TherapeuticsChief Executive Officer and President$10M2016
TG TherapeuticsChief Executive Officer and President$4M2016
Fortress BiotechExecutive Vice Chairman, Strategic Development$2M2015
TG TherapeuticsChief Executive Officer and President$14M2015
Fortress BiotechExecutive Vice Chairman, Strategic Development$3M2014
Fortress BiotechExecutive Vice Chairman, Strategic Development$11M2012
TG TherapeuticsExecutive Chairman, Interim Chief Executive Officer and President$11M2011
TG TherapeuticsExecutive Chairman, Interim Chief Executive Officer and President$2M2009
Keryx BiopharmaceuticalsFormer Chairman and Chief Executive Officer$2MSource: SEC filings on April 30, 2019, April 30, 2018, April 26, 2017, April 24, 2013, April 30, 2010, and April 29, 2008.
Related executives
We found 20 more executives who work or worked at TG Therapeutics, Fortress Biotech, andKeryx Biopharmaceuticals.
Sean Power
TG Therapeutics
Chief Financial Officer
Gregory Madison
Keryx Biopharmaceuticals
Chief Executive Officer
Christine Carberry
Keryx Biopharmaceuticals
Chief Operating Officer
John Neylan
Keryx Biopharmaceuticals
Chief Medical Officer
Scott Holmes
Keryx Biopharmaceuticals
Chief Financial Officer
Brian Adams
Keryx Biopharmaceuticals
General Counsel
Lindsay Rosenwald
Fortress Biotech
Chief Executive Officer
George Avgerinos
Fortress Biotech